Neurocrine Biosciences Earnings Estimate

By analyzing Neurocrine Biosciences' earnings estimates, investors can diagnose different trends across Neurocrine Biosciences' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Neurocrine Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options. Neurocrine Biosciences is projected to generate 1.635625 in earnings per share on the 31st of December 2024. Neurocrine Biosciences earnings estimates show analyst consensus about projected Neurocrine Biosciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Neurocrine Biosciences' historical volatility. Many public companies, such as Neurocrine Biosciences, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Neurocrine Biosciences Revenue Breakdown by Earning Segment

By analyzing Neurocrine Biosciences' earnings estimates, investors can diagnose different trends across Neurocrine Biosciences' analyst sentiment over time as well as compare current estimates against different timeframes. Gross Profit is likely to rise to about 1.9 B in 2024. Pretax Profit Margin is likely to rise to 0.18 in 2024Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neurocrine Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Neurocrine Stock please use our How to Invest in Neurocrine Biosciences guide.